NeuroPace, Inc. (NPCE) Financial Analysis & Valuation | Quarter Chart

NeuroPace, Inc. (NPCE)

NPCE
Price: $16.53
Fair Value: 🔒
🔒score
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system ... more
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS... more
Description Shares
Market Cap$556.51MExchangeNASDAQ
SectorHealthcareIndustryMedical - Devices
CountryUSCEOJoel D. Becker
IPO Date2021-04-22CAGR0.18%
Employees184Websitewww.neuropace.com
Div. YieldPayout Ratio
Buy Back Yield5.79%Total Yield5.79%
NPCE chart loading...
Fundamentals Technicals
Enterprise Value$646.25MP/E Ratio-25.05
Forward P/E-48.46PEG Ratio
P/S Ratio8.53P/B Ratio44.14
P/CF Ratio-76.31P/FCF Ratio-76.05
EPS$-0.66EPS Growth 1Y-30.53%
EPS Growth 3Y-65.62%EPS Growth 5Y-62.13%
Revenue Growth 1Y25.13%Gross Margin0.77%
Operating Margin-0.16%Profit Margin-0.32%
ROE-1.57%ROA-0.3%
ROCE-0.19%Current Ratio5.28
Quick Ratio4.33Cash Ratio1.22
Debt/Equity3.72Interest Coverage-1
Altman Z Score-2.25Piotroski Score3